Skip to main content
Caplight Logo









Pharmasaga Co., Ltd.

Pharmasaga Co., Ltd.

Private
TaiwanHealthcare & Life Scienceshttps://www.pharmasaga.com/en-us/

Last Round

Pre Seed

Oct 29, 2023

Est. Valuation

$6.82M

Total Funding Raised

$3.72M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Pharmasaga Co., Ltd. is a clinical-stage biotechnology company that develops novel small-molecule drugs for the treatment of diabetes.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverysmall-molecule drugsdiabetes treatmentbiotech startupdrug out-licensingPdia4 inhibitordrug screening platformmolecular dockingpancreatic beta-cell failurefirst-in-class therapyclinical-stage biotechpharma partneringdrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pharmasaga Co., Ltd. Comparables

Compare Pharmasaga Co., Ltd. with similar companies based on industry and business-model similarity.

Pharmasaga Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
TIXiMED
84%
ASAKE Biotechnology, LLC
81%
Abarceo Pharma
80%

Pharmasaga Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedOct 29, 2023

Key People

Founding team and executive leadership

Mau-Sheng Hou

Chief Technology Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 3, 2026

    Job postings increased from 0 to 3 roles, representing 50% of headcount.

  • Mar 2, 2026

    Monthly visitors increased 40% MoM, from 559 to 784.

Recent news

Latest coverage and updates

  • attends_eventJun 23, 2026

    Pharmasaga attended event US BIO Convention 2026 on Jun 22nd '26.

Pharmasaga Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Pharmasaga Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Pharmasaga Co., Ltd.'s valuation, stock price, and market status.

Is Pharmasaga Co., Ltd. a public or private company?

Pharmasaga Co., Ltd. is a private company.

What is the current stock price of Pharmasaga Co., Ltd.?

Pharmasaga Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is Pharmasaga Co., Ltd. worth (valuation)?

Pharmasaga Co., Ltd.'s valuation is estimated at $6.8M based on funding round data.

Can I buy Pharmasaga Co., Ltd. stock?

Pharmasaga Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Pharmasaga Co., Ltd.'s last funding round?

Pharmasaga Co., Ltd.'s most recent funding round was Pre Seed on October 29, 2023.

Who are the main investors in Pharmasaga Co., Ltd.?

Investor information for Pharmasaga Co., Ltd. is not publicly disclosed.

Will Pharmasaga Co., Ltd. IPO soon?

No public IPO plans have been announced for Pharmasaga Co., Ltd..

How can I track Pharmasaga Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pharmasaga Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTaiwan
Employee Range6
Year Founded2021
Last FundingOct 29, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?